EFFICACY OF PHACOEMULSIFICATION AND PHACOEMULSIFICATION COMBINED WITH GONIOSYNECHIALYSIS IN SURGICAL TREATMENT OF CHRONIC ANGLE-CLOSURE GLAUCOMA: 2-YEARS STUDY
Aim. To study the degree of angle opening and the decrease of intraocular pressure in primary angle-closure glaucoma (PACG) after cataract phacoemulsification and cataract phacoemulsification with goniosynechialysis (phaco + GLS).
Materials and Methods. The study involved 28 patients (28 eyes) with primary chronic angle-closure glaucoma. The patients were divided into two groups, group 1 of 15 patients undergoing phaco with posterior chamber IOL implantation, and group 2 of 13 patients undergoing phaco with IOL implantation and GLS. The patients were followed for 24 months. Phaco was indicated in cases with IOP above 22 mmHg, appositional anterior chamber angle closure, and optic neuropathy; Phaco with GSL was indicated in cases of synechial angle closure and IOP above 22 mmHg
Results. In group 1 after Phaco, postoperative anterior chamber angle opening was >20° in all quadrants. Postoperative IOP after 24 month follow-up it decreased by 32,6 % from the preoperative levels. In group 2 after Phaco+GSL, anterior chamber angle opened at least to 20° in three or more quadrants in all cases. Postoperative IOP after 24 month follow-up it decreased by 33.0% from the preoperative levels.
Conclusions. Thus, phacoemulsification is an efficient procedure for PACG and appositional angle closure, leading to reopening of the anterior chamber angle with significant IOP reduction. Phacoemulsification alone does not lead to reopening of anterior chamber angle in cases with synechial angle closure, necessitating a combined surgery of phacoemulsification with GSL.
Harasymowycz Paul J., Demosthenes G. Papamatheakis, Iqbal Ahmed, Alfred Assalian, Mark Lesk, Yousif Al-Zafiri, Christoph Kranemann, Cindy Hutnik.//Phacoemulsification and Goniosynechialysis in the Management of Unresponsive Primary Angle Closure//J Glaucoma - 2005 - Jun;14(3):186-9. - doi: 10.1097/01.ijg.0000159131.38828.85.
Hayashi Ken, Hayashi Hideyuki, Nakao Fuminori, Hayashi Fumihiko //Effect of cataract surgery on intraocular pressure control in glaucoma patients//J Cataract Refract Surg2001 Nov;27(11):1779-86. - doi: 10.1016/s0886-3350(01)01036-7.
Mou Da-Peng,Liang Yuan-Bo, Fan Su-Jie, Peng Yi, Wang Ning-Li, and Thomas Ravi //Progression rate to primary angle closure following laser peripheral iridotomy in primary angle-closure suspects: a randomised study//Int J Ophthalmol - 2021; 14(8): 1179-1184. - doi:10.18240/ijo.2021.08.07
Ritch Robert, Teekhasaene Chaiwat //Combined Phacoemulsification and Goniosynechialysis for Uncontrolled Chronic Angle-closure Glaucoma after Acute Angle-closure Glaucoma//Ophthalmology 1999;106:669 - doi: 10.1016/S0161-6420(99)90149-5.
Tham Clement C. Y., Kwong Yolanda Y. Y., Dexter Leung Y. L. , Lam S. W. , Li Felix C. H. , Chiu Thomas Y. H., Chan Jonathan C. H., Lam Dennis S. C., Lai Jimmy S. M. .//Phacoemulsification versus Combined Phacotrabeculectomy in Medically Uncontrolled Chronic Angle Closure Glaucoma with Cataracts//Ophthalmology2009 Apr;116(4):725-31, 731.e1-3. - doi: 10.1016/j.ophtha.2008.12.054.
Tian Tian, Mei Li, Yingzi Pan, Yu Cai and Yuan Fang//The effect of phacoemulsification plus goniosynechialysis in acute and chronic angle closure patients with extensive goniosynechiae//BMC Ophthalmology (2019) 19:65 - doi: 10.1186/s12886-019-1070-9.
Varma D. K., Simpson S. M., Rai A. S., Ahmed I. K. //Undetected angle closure in patients with a diagnosis of open-angle glaucoma // Can J Ophthalmol2017 Aug;52(4):373-378. - doi:10.1016/j.jcjo.2016.12.010
White Andrew JR, Justo Manuel A Orros, Paul R Healey //Outcomes of combined lens extraction and goniosynechialysis in angle closure//Clinical and Experimental Ophthalmology 2013; 41: 746-752 - doi: 10.1111/ceo.12121
Zhang Hengli, Guangxian Tang, Jie Liu //Effects of Phacoemulsification Combined With Goniosynechialysis on Primary Angle-closure Glaucoma//J Glaucoma 2016 May;25(5):e499-503. - doi: 10.1097/IJG.0000000000000297.
This work is licensed under a Creative Commons Attribution 4.0 International License.